Glucose Intolerance after a Recent History of Gestational Diabetes
Table 1
Comparison of the characteristics between women who received an OGTT postpartum and women who failed to attend the scheduled OGTT postpartum.
Women with OGTT postpartum (78.6%)
Women without OGTT postpartum (21.4%)
value
Age mean years
32.2 ± 4.7
31.5 ± 4.9
0.349
% overweight at first prenatal visit
31.9
40.9
0.195
% obese at first prenatal visit
23.1
25.0
0.795
% BME
33.7
37.0
0.683
% smoking before pregnancy
2.4
10.9
0.021
% first degree family member with T2DM
15.4
13.0
0.580
% history of GDM
10.7
21.7
0.042
% multiparous
34.3
34.8
0.872
% breastfeeding
75.7
56.5
0.011
Week OGTT (median)
27.0 (25.0–28.2)
27.0 (25.0–29.0)
0.520
% fasting abnormal
42.3
45.0
0.759
% ≥4 values abnormal on the 100 g OGTT
13.5
17.9
0.475
% insulin
28.6
26.1
0.818
Weeks start insulin (median)
29.5 (27.0–32.0)
30.0 (27.0–33.0)
0.582
% bolus-basal injections
35.4
33.3
0.786
pISSI-2 mean
1.6 ± 0.4
1.6 ± 0.6
0.690
pMatsuda (median)
2.8 (1.9–3.8)
2.2 (1.5–3.1)
0.033
p1/HOMA-IR (median)
0.020 (0.012–0.032)
0.015 (0.010–0.023)
0.030
BME: ethnic minority backgrounds; T2DM: type 2 diabetes; GDM: gestational diabetes; OGTT: oral glucose tolerance test; pISSI-2: insulin secretion sensitivity index during pregnancy; pMatsuda: insulin sensitivity index of Matsuda during pregnancy; p1/HOMA-IR: the reciprocal of the homeostasis model assessment of insulin resistance during pregnancy.
